Mon.Aug 26, 2024

article thumbnail

STAT+: Continuous glucose monitoring for the masses is here. Are we ready for it?

STAT

NEW YORK — Glucose tracking is the future, Dexcom executives gushed at a glitzy launch event for their new, over-the-counter continuous glucose monitor on Wednesday evening. Surrounded by champagne, new celebrity ambassador and “Parks and Rec” actress Retta, and a mini-pickleball court, CEO Kevin Sayer declared victory.   “Dexcom has literally created an industry, and now it’s time to create a much broader revolution in health care,” Sayer told

Diabetes 351
article thumbnail

Pharmacogenomics: The Up-and-Coming Field of Pharmacy

Pharmacy Is Right For Me

What is your first thought when you think of a career in pharmacy? You may think of a clinical pharmacist working in a community pharmacy or a hospital pharmacist working in an in-patient unit. But did you think about pharmacogenomics: the field of pharmacy that studies how someone’s genetics affect their response to a certain drug? Not many people are aware of the field of pharmacogenomics, and how it can optimize patient outcomes.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Opinion: Why Harvard, Penn, and Columbia have turned to M.D.s for leadership in troubled times

STAT

Recently, Columbia University’s president resigned after months of chaos, following in the footsteps of Harvard and my own institution, Penn. Besides struggling with encampments, building takeovers, and commencement challenges, the three universities have something else in common: They have all chosen M.D.s as president or interim president.

355
355
article thumbnail

SAEM Clinical Images Series: An Interesting Case of Ocular Trauma

ALiEM - Pharm Pearls

A 27-year-old male with no past medical history presents to the Emergency Department with right eye pain. He states that approximately one week prior, he was working on a wire fence when he lost hold of a wire under tension, and it subsequently hit him in his right eye. He had immediate pain in his affected eye and was unable to see anything but light for the next three days.

177
177
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Opinion: Who should get to see the neurologist first: the sick or the at-risk?

STAT

Once a year, Jessi Keavney goes to see her neurologist. During the visit, the doctor asks if she has developed any new symptoms and then performs a detailed physical exam. He observes the speed and amplitude of her hand and foot movements, and then assesses her ability to stand from a seated position. While she walks, the doctor evaluates her arm swing, the length of her stride, and her posture.

319
319
article thumbnail

As a new mpox strain gains ground, a key drug stumbles in the clinic

PharmaVoice

Despite the disappointing results, the drug’s developer, Siga Therapeutics, said there’s more to the story.

147
147

More Trending

article thumbnail

Pharmas’ IRA court losses mount. They keep pursuing them.

PharmaVoice

The final drug prices for Medicare’s negotiation program have been published, but pharma companies continue to push their legal strategies.

article thumbnail

A Galapagos investor signals impatience with its turnaround efforts

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. And hello again! Miss us?

article thumbnail

PulmCrit Wee – A better classification of heart failure (HFxEF-RVxEF)

EMCrit Project

We often joke that the right ventricle is the “forgotten ventricle,” but there is a sad truth behind this joke. Recently, there has been increased recognition of the importance of right ventricle failure and systemic congestion within some circles (e.g., nephrologists and resuscitationists). However, overall the right ventricular failure continues to be commonly overlooked.

138
138
article thumbnail

A virus bodega, DNC takeaways, and free Covid tests

STAT

Want to stay on top of health news?  Sign up  to get our Morning Rounds newsletter in your inbox. Happy Eldest Daughter Day. I am not the first daughter in my family, but I was always the oldest sibling in the house while growing up. I’m often willing to indulge in a discussion of that burden, but I saw the movie “Dìdi” this weekend.

227
227
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

J&J's bid to change pay model for Stelara, Xarelto slammed

pharmaphorum

A US government agency has hit back at a plan by Johnson & Johnson to change the way it pays discounts on drugs to hospitals in the controversial 340B programme

Hospitals 119
article thumbnail

STAT+: Pharmalittle: UCB selling a Chinese business, Tome layoffs, and more

STAT

Happy Monday, Pharmalittle family. Adam Feuerstein here, once again filling in for Ed. I have been assured that Ed is staying caffeinated, even in his absence. Let’s take a look at some morning news. … Belgian drugmaker UCB is selling its Chinese neurology and allergy business to Singapore-based asset management group CBC and Abu Dhabi sovereign investor Mubadala for $680 million , Reuters tells us.

article thumbnail

Tome Biosciences to lay off over 100 employees

BioPharma Dive

The buzzy startup, which had raised over $200 million in venture funding, is letting go of much of its workforce, according to a state regulatory notice.

114
114
article thumbnail

DEA To Announce Hearing on Proposed Marijuana Rescheduling

FDA Law Blog: Biosimilars

By Larry K. Houck — Who says nothing happens in Washington, D.C., in August? The Drug Enforcement Administration (“DEA”) will announce Thursday in the Federal Register that it will hold a hearing on the proposed rescheduling of marijuana to schedule III at DEA Headquarters in Arlington, Virginia on December 2, 2024. DEA received over 43,500 public comments in response to the agency’s Notice of Proposed Rulemaking in the Federal Register on May 21, 2024.

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

European Commission Approves Merck Treatment Combined with Other Therapies for Pulmonary Arterial Hypertension

PharmaTech

In a 24-week study of patients with PAH, six-minute walking distance improved by an average of 40.8 meters, and risk of death or clinical worsening was reduced by 82%.

98
article thumbnail

Insud Pharma completes acquisition of Agile Therapeutics

Express Pharma

Agile Therapeutics (“Agile”), a women’s healthcare company, has announced the completion of the acquisition of Agile by Insud Pharma, S.L. a global pharmaceutical group based in Spain with a 45-year track record and a presence in over 50 countries. The former holders of Agile common stock voted to approve the acquisition at a special meeting of stockholders on August 22, 2024.

104
104
article thumbnail

FDA Grants Orphan Drug Designation to RedHill’s Treatment for Neuroblastoma

PharmaTech

Opaganib was given orphan drug designation for the treatment of neuroblastoma in children, which is rare, but the most common infancy malignancy.

98
article thumbnail

Changing Faces – Agency, consultancy, and investor hires from July 2024

pharmaphorum

Changing Faces – Agency, consultancy, and investor hires from July 2024: Stay updated on the latest hires at EVERSANA, Ogilvy Health, Skarbek, and more in the industry.

98
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

China pharma firms eye stronghold in therapeutic cancer vaccines market: GlobalData

Express Pharma

Cancer vaccines represent a burgeoning field in oncology, with the potential to revolutionise cancer treatment. Earlier, approved cancer vaccines were prophylactic against cancer-causing viruses. However, recent advancements have shifted towards developing therapeutic cancer vaccines, which focus on identifying tumour-specific antigens to create innovative cancer immunotherapies.

Vaccines 102
article thumbnail

Game-changing needle-free COVID-19 intranasal vaccine

World Pharma News

A next-generation COVID-19 mucosal vaccine is set to be a gamechanger not only when delivering the vaccine itself, but also for people who are needle-phobic. New Griffith University research, published in Nature Communications, has been testing the efficacy of delivering a COVID-19 vaccine via the nasal passages. Professor Suresh Mahalingam from Griffith's Institute for Biomedicine and Glycomics has been working on this research for the past four years.

article thumbnail

Versant’s Jerel Davis on build-to-buy deals and pharma investment

BioPharma Dive

Build-to-buy arrangements can give pharmaceutical companies an option to acquire a startup’s assets later, as with Novartis’ deal with the Versant-backed Borealis Biosciences.

article thumbnail

European Commission licenses first treatment for acanthamoeba keratitis

European Pharmaceutical Review

The European Commission has granted the first approval for a medicine to treat acanthamoeba keratitis, an ultra-rare corneal infection that can lead to blindness. Akantior ® (polihexanide) is indicated for individuals from 12 years old in Europe. SIFI, the international ophthalmic company that developed Akantior, explained that the parasitic infection is caused by the free-living amoeba, acanthamoeba.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Regeneron gains European approval for bispecific lymphoma drug

BioPharma Dive

Regulators in Europe granted approval based on remission rates, while the FDA sought more progress in confirmatory trials when it rejected Ordspono.

70
article thumbnail

Mixed reactions among HCPs as lecanemab and donanemab secure FDA approval for Alzheimer's treatment

pharmaphorum

Mixed reactions among HCPs as lecanemab and donanemab secure FDA approval for Alzheimer's treatment Mike.

97
article thumbnail

The Pros and Cons of Different CDMO Models

Drug Patent Watch

The pharmaceutical industry has increasingly relied on Contract Development and Manufacturing Organizations (CDMOs) to support the development and commercialization of drugs. CDMOs offer a range of services, from drug development to manufacturing, allowing pharmaceutical companies to focus on their core competencies.

article thumbnail

Moderna’s RSV vaccine mRESVIA gains EC approval

Pharmaceutical Business Review

This follows a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) and is valid across all 27 EU member states, as well as Liechtenstein, Iceland and Norway. The approval of mRESVIA is underpinned by the Phase III ConquerRSV clinical trial, which involved roughly 37,000 adults aged 60 or above across 22 countries.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

EMA Accepts Marketing Authorization Application for Alvotech’s AVT06 (aflibercept)

Big Molecule Watch

On August 15, 2024, Alvotech and Advanz Pharma announced that the European Medicines Agency (EMA) has accepted a Marketing Authorization Application for AVT06, Alvotech’s biosimilar of low dose (2 mg) EYLEA (aflibercept). Alvotech states that it expects that the process to obtain final market authorization could be completed by the third quarter of 2025.

article thumbnail

IPHEX 2024 to kick off on August 28 with major Indian and international pharma presence

Express Pharma

The three-day International Exhibition for Pharma and Healthcare (IPHEX 2024) is set to begin on August 28, 2024, at India Expo Mart in Greater Noida. Organised by the Pharmaceutical Export Promotion Council of India (PHARMEXCIL) in collaboration with the Union Ministry of Commerce and Industry, the event will feature over 400 major Indian pharmaceutical companies showcasing their products and technologies.

article thumbnail

Healthineers offers €200m for Novartis radiodiagnostics unit

pharmaphorum

Siemens Healthineers has agreed a $224m deal to buy the diagnostic arm of Novartis' AAA radiopharmaceuticals unit

64
article thumbnail

The Capabilities of a 3PL Provider

Pharmaceutical Commerce

Chris Williams expands on the services that a third-party logistics (3PL) partner should offer, while sharing ways to alleviate standard supply chain issues.

52
article thumbnail

MSD snags European approval for pulmonary arterial hypertension therapy

Pharmaceutical Technology

Winrevair is the first approved actin signaling pathway-targeting therapy for the treatment of the rare blood vessel disorder.

59